A unique study published this month outlines new ways to protect more of the world's population from vaccine-preventable diseases.
Apr 26, 2023
0
29
Researchers have conducted one of the first studies to examine the effectiveness of nirmatrelvir-ritonavir (Paxlovid) in non-hospitalized patients during an omicron period of the COVID-19 pandemic that includes BA.4 and BA.5 ...
Feb 10, 2023
2
84
Researchers from Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania found that one in five newborn babies may not have measles antibodies passed down from their ...
Feb 3, 2023
2
90
High levels of mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months. Omicron infection generates durable mucosal antibodies, reducing the risk of re-infection. These are the ...
Jan 16, 2023
0
37
World-first immunizations providing protection against deadly respiratory syncytial virus (RSV) could be just months away thanks to global research efforts spanning multiple decades.
Aug 23, 2022
0
173
Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared ...
Apr 13, 2021
0
94
Test and trace could reduce the effective reproduction number, the R number, by up to 26% if carried out quickly and effectively, new research finds.
Aug 19, 2020
0
152
The Lancet on Thursday retracted a study that raised safety fears over the use of a drug favored by President Donald Trump to treat COVID-19, after the paper's authors said they could no longer vouch for its underlying data.
Jun 4, 2020
9
651
A new study led by an infectious disease epidemiologist at Tulane University School of Public Health and Tropical Medicine could change the way doctors treat a common sexually transmitted disease.
Oct 5, 2018
2
88
The Lancet medical journal Friday withdrew two papers authored by disgraced Italian surgeon Paolo Macchiarini, found guilty of misconduct regarding an experimental windpipe graft procedure of which most recipients died.
Jul 6, 2018
1
36
